Disease-specific Reference Equations for Lung Function in Patients with Cystic Fibrosis
- 1 October 2005
- journal article
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 172 (7), 885-891
- https://doi.org/10.1164/rccm.200410-1335oc
Abstract
Forced expiratory volume in one second (FEV1), an important measure of pulmonary disease severity in patients with cystic fibrosis (CF), is frequently expressed as a percentage of a predicted value derived from a healthy reference population. There are limitations to comparing the lung function of a patient with CF to that of healthy control subjects, and potential advantages to comparing it to that of other patients with CF.To estimate CF-specific percentiles of FEV1 as functions of height, age, and sex.We used 287,108 FEV1 observations among more than 21,000 patients with CF in the CF Foundation National Patient Registry between 1994 and 2001. The percentiles were estimated using quantile regression methods.FEV1 percentile "growth grids" are presented, allowing comparison of an individual's FEV1 to that of patients with CF of the same sex, age, and height. Their potential uses in clinical practice and research are illustrated.CF-specific reference equations allow individual patients' FEV1 to be placed in the context of the distribution of lung function of their peers with CF, and should improve generalizability of CF clinical trials by setting entry criteria that are equitable across sex and age ranges. They may serve as a useful adjunct to conventional reference equations.Keywords
This publication has 21 references indexed in Scilit:
- Azithromycin in Patients With Cystic Fibrosis Chronically Infected With Pseudomonas aeruginosaJAMA, 2003
- Intermittent Administration of Inhaled Tobramycin in Patients with Cystic FibrosisNew England Journal of Medicine, 1999
- International Guidelines for the Selection of Lung Transplant CandidatesAmerican Journal of Respiratory and Critical Care Medicine, 1998
- Identifying Treatments That Halt Progression of Pulmonary Disease in Cystic FibrosisPediatric Research, 1997
- Standardization of Spirometry, 1994 Update. American Thoracic Society.American Journal of Respiratory and Critical Care Medicine, 1995
- Effect of High-Dose Ibuprofen in Patients with Cystic FibrosisNew England Journal of Medicine, 1995
- Outcome measures for clinical trials in cystic fibrosis Summary of a Cystic Fibrosis Foundation Consensus ConferenceThe Journal of Pediatrics, 1994
- Efficacy and Safety of Short-term Administration of Aerosolized Recombinant Human Deoxyribonuclease in Patients with Cystic FibrosisAmerican Review of Respiratory Disease, 1993
- Prediction of Mortality in Patients with Cystic FibrosisNew England Journal of Medicine, 1992
- Lung Function Testing: Selection of Reference Values and Interpretative StrategiesAmerican Review of Respiratory Disease, 1991